Evaluation of Listeria monocytogenes Based Vaccines for HER-2/Neu in Mouse Transgenic Models of Breast Cancer

Mapping Intimacies ◽

10.21236/ada435097 ◽

2005 ◽

Author(s):

Reshma Singh

Keyword(s):

Breast Cancer ◽

Listeria Monocytogenes ◽

Transgenic Models ◽

Her 2

Download Full-text

Evaluation of Listeria Monocytogenes Based Vaccines for HER-2/neu in Mouse Transgenic Models of Breast Cancer

10.21236/ada475558 ◽

2007 ◽

Author(s):

Jeff H. Tsai ◽

William M. Lee

Keyword(s):

Breast Cancer ◽

Listeria Monocytogenes ◽

Transgenic Models ◽

Her 2

Download Full-text

Evaluation of Listeria Monocytogenes Based Vaccines for HER-2/neu in Mouse Transgenic Models of Breast Cancer

10.21236/ada450490 ◽

2006 ◽

Author(s):

Reshma Singh

Keyword(s):

Breast Cancer ◽

Listeria Monocytogenes ◽

Transgenic Models ◽

Her 2

Download Full-text

Jab1 is overexpressed in human breast cancer and is a downstream target for HER-2/neu

Modern Pathology ◽

10.1038/mpath.2008.23 ◽

2008 ◽

Author(s):

Ming-Chuan Hsu ◽

Chee-Yin Chai ◽

Ming-Feng Hou ◽

Hui-Chiu Chang ◽

Wan-Tzu Chen ◽

...

Keyword(s):

Breast Cancer ◽

Human Breast Cancer ◽

Human Breast ◽

Downstream Target ◽

Her 2

Download Full-text

Neoadjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct04126525 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Her 2 ◽

Positive Breast Cancer

Download Full-text

Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct04254263 ◽

2020 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Her 2 ◽

Positive Breast Cancer

Download Full-text

Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct04290793 ◽

2020 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Her 2

Download Full-text

Faculty Opinions recommendation of Clinical efficacy of taxane-trastuzumab combination regimens for HER-2-positive metastatic breast cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1115159.571150 ◽

2008 ◽

Author(s):

Gilberto Schwartsmann ◽

Fabio Leal

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Clinical Efficacy ◽

Metastatic Breast ◽

Her 2 ◽

Combination Regimens

Download Full-text

Faculty Opinions recommendation of Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.722359397.793506868 ◽

2015 ◽

Author(s):

Kent Hunter

Keyword(s):

Breast Cancer ◽

Primary Breast Cancer ◽

Her 2 ◽

Metastatic Sites

Download Full-text

Oral Contraceptive Use and HER-2/neu-Positive Breast Cancer Among White and Black Women.

10.21236/ada306141 ◽

1996 ◽

Author(s):

Marilie Gammon

Keyword(s):

Breast Cancer ◽

Oral Contraceptive ◽

Black Women ◽

Contraceptive Use ◽

Oral Contraceptive Use ◽

Her 2 ◽

Positive Breast Cancer

Download Full-text

Targeting Human Breast Cancer Cells that Overexpress HER-2/neu mRNA by an Antisense Iron Responsive Element

10.21236/ada390720 ◽

2000 ◽

Author(s):

Duen-Hwa Yan

Keyword(s):

Breast Cancer ◽

Cancer Cells ◽

Human Breast Cancer ◽

Breast Cancer Cells ◽

Human Breast Cancer Cells ◽

Human Breast ◽

Iron Responsive Element ◽

Her 2 ◽

Responsive Element

Download Full-text